Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Live at MJAC 2017 Saturday 2nd September - 4.05 PM on Streaming Stage F How venture capital and cryptocurrency are converging as the future of cannabis investing ...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Book your ticket now for InvestorsHubs International Cannabis Conference For a...
Session: Friday 1st Sept 16:05 - 17:15 Investing in the U.S. Cannabis Market ...
Easton Pharmaceuticals and BMV Medica Announces First Shipment of “Gynofit” To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been...
iBliss’s Current Sales Are In the Millions Of Dollars and Are Projected To Quickly Reach and Surpass $15,000,000 in Sales With Healthy Profit Margins in Excess of 40% TORONTO, ON...
Easton Pharmaceuticals and Partner BMV Medica Sign First Sales & Marketing Agreement with European Based, Multi-National Pharmaceutical Company, Gedeon...
Easton Pharmaceuticals Discloses Existing Medicated Market Revenues From Its Medical Marijuana Operations That Have Surpassed $2,000,000; Provides Clarification on Other...
Daily OTC Stocks Trading List: Easton Pharmaceuticals, Inc. Virtus Oil and Gas Corp, Primco Management, Inc. Baltia Airlines, Inc. Alternative Fuels America, Inc. PR Newswire LONDON, December 30...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 3933 | 1.0E-6 | CS |
| 4 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 79831 | 1.0E-6 | CS |
| 12 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 55588 | 1.0E-6 | CS |
| 26 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 81304 | 1.0E-6 | CS |
| 52 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 63881 | 1.43E-6 | CS |
| 156 | -0.000199 | -99.5 | 0.0002 | 0.0002 | 1.0E-6 | 92309 | 3.613E-5 | CS |
| 260 | -0.001699 | -99.9411764706 | 0.0017 | 0.019 | 1.0E-6 | 565603 | 0.00105983 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
